These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22910291)

  • 1. 1α,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trial.
    De Luna N; Díaz-Manera J; Paradas C; Iturriaga C; Rojas-García R; Araque J; Genebriera M; Gich I; Illa I; Gallardo E
    Mol Ther; 2012 Oct; 20(10):1988-97. PubMed ID: 22910291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic determinants of low dysferlin expression in monocytes.
    Gallardo E; Ankala A; Núñez-Álvarez Y; Hegde M; Diaz-Manera J; Luna ND; Pastoret A; Suelves M; Illa I
    Hum Mutat; 2014 Aug; 35(8):990-7. PubMed ID: 24838345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy.
    Gallardo E; de Luna N; Diaz-Manera J; Rojas-García R; Gonzalez-Quereda L; Flix B; de Morrée A; van der Maarel S; Illa I
    PLoS One; 2011; 6(12):e29061. PubMed ID: 22194990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysferlin regulates cell adhesion in human monocytes.
    de Morrée A; Flix B; Bagaric I; Wang J; van den Boogaard M; Grand Moursel L; Frants RR; Illa I; Gallardo E; Toes R; van der Maarel SM
    J Biol Chem; 2013 May; 288(20):14147-14157. PubMed ID: 23558685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes.
    Cea LA; Bevilacqua JA; Arriagada C; Cárdenas AM; Bigot A; Mouly V; Sáez JC; Caviedes P
    BMC Cell Biol; 2016 May; 17 Suppl 1(Suppl 1):15. PubMed ID: 27229680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolabelling and flow cytometry as new tools to explore dysferlinopathies.
    Wein N; Krahn M; Courrier S; Bartoli M; Salort-Campana E; Nguyen K; Fernandez C; Pouget J; Fossat C; Depetris D; Leturcq F; Cau P; Levy N
    Neuromuscul Disord; 2010 Jan; 20(1):57-60. PubMed ID: 19854055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibitors increase missense mutated dysferlin in patients with muscular dystrophy.
    Azakir BA; Erne B; Di Fulvio S; Stirnimann G; Sinnreich M
    Sci Transl Med; 2014 Aug; 6(250):250ra112. PubMed ID: 25143362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysferlin quantification in monocytes for rapid screening for dysferlinopathies.
    Sánchez-Chapul L; Ángel-Muñoz MD; Ruano-Calderón L; Luna-Angulo A; Coral-Vázquez R; Hernández-Hernández Ó; Magaña JJ; León-Hernández SR; Escobar-Cedillo RE; Vargas S
    Muscle Nerve; 2016 Dec; 54(6):1064-1071. PubMed ID: 27104310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
    De Luna N; Freixas A; Gallano P; Caselles L; Rojas-García R; Paradas C; Nogales G; Dominguez-Perles R; Gonzalez-Quereda L; Vílchez JJ; Márquez C; Bautista J; Guerrero A; Salazar JA; Pou A; Illa I; Gallardo E
    Neuromuscul Disord; 2007 Jan; 17(1):69-76. PubMed ID: 17070050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
    Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
    Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
    Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
    Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
    Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
    Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational research and therapeutic perspectives in dysferlinopathies.
    Barthélémy F; Wein N; Krahn M; Lévy N; Bartoli M
    Mol Med; 2011; 17(9-10):875-82. PubMed ID: 21556485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
    Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.
    Cagliani R; Magri F; Toscano A; Merlini L; Fortunato F; Lamperti C; Rodolico C; Prelle A; Sironi M; Aguennouz M; Ciscato P; Uncini A; Moggio M; Bresolin N; Comi GP
    Hum Mutat; 2005 Sep; 26(3):283. PubMed ID: 16100712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
    De Luna N; Gallardo E; Sonnet C; Chazaud B; Dominguez-Perles R; Suarez-Calvet X; Gherardi RK; Illa I
    J Neuropathol Exp Neurol; 2010 Jun; 69(6):643-53. PubMed ID: 20467328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
    Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
    FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
    Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
    Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele.
    Meznaric M; Gonzalez-Quereda L; Gallardo E; de Luna N; Gallano P; Fanin M; Angelini C; Peterlin B; Zidar J
    Eur J Neurol; 2011 Jul; 18(7):1021-3. PubMed ID: 21658164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity.
    Demonbreun AR; Rossi AE; Alvarez MG; Swanson KE; Deveaux HK; Earley JU; Hadhazy M; Vohra R; Walter GA; Pytel P; McNally EM
    Am J Pathol; 2014 Jan; 184(1):248-59. PubMed ID: 24177035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.